Novavax, Inc. (NVAX)

Biotechnology

NVAX · NASDAQ NMS - GLOBAL MARKET · USD

New to investing? How to read this page →

$9.74

+2.96%

Watch Compare

Price · 1 year

Watch + Add to portfolio

Loading live analysis…

Loading analysis…

Intrinsic Investor is for education and research only — not financial advice.

Key metrics

EPS

$2.54

ROE

Gross margin

27.5%

Debt/Equity

Revenue growth

-79.1%

P/B ratio

Beta

Forward P/E

Novavax, Inc. — company intelligence

Earnings surprises

Q1 2026$-0.06 vs $-0.23 est+74.5%

Q4 2025$0.11 vs $-0.50 est+122.1%

Q3 2025$-1.25 vs $-1.21 est-3.3%

Q2 2025$0.62 vs $-0.09 est+827.7%

Insider activity · 90 days

18 buys0 sellsnet +449,100 shares

MOTT DAVID Mother 18,880 · Jun 20, 2026

Rodgers Richard Jother 18,880 · Jun 20, 2026

DOUGLAS RICHARDother 18,880 · Jun 20, 2026

Recent SEC filings

4 — Insider transaction reportJun 23, 2026

Latest news

Moderna: The Comeback Is Now In Full Swing — SeekingAlpha · 2w ago

Novavax (NVAX) Stock Falls Amid Market Uptick: What Investors Need to Know — Yahoo · 3w ago

Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax? — Yahoo · 3w ago

A Look Back at Therapeutics Stocks’ Q1 Earnings: Novavax (NASDAQ:NVAX) Vs The Rest Of The Pack — Yahoo · 3w ago

Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade — Yahoo · 4w ago

AI Valuation Narrative

Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.

Screen Stocks Learn Intrinsic Value Trading Signals Compare Stocks

Explore more

More in Biotechnology →More in Biotechnology →Stocks in US →Stocks on NASDAQ NMS - GLOBAL MARKET →Compare stocks side-by-side →

Peers & similar stocks

Quick links to related tickers for research.

AbbVie IncABBV Amgen Inc.AMGN Gilead Sciences, Inc.GILD Vertex Pharmaceuticals IncorporVRTX Regeneron Pharmaceuticals, Inc.REGN Revolution Medicines IncRVMD

About Novavax, Inc.

Weekly undervalued picks (like NVAX)

Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.

Free. No spam. We only email once per week.

Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.